当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析

泓博医药

(301230)

  

流通市值:25.43亿  总市值:46.19亿
流通股本:7686.03万   总股本:1.40亿

泓博医药(301230)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.12亿元,每股收益0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益104624.42万元,未分配利润16144.92万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产133127.00万元,负债28502.58万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入169,429,129.41544,471,262.04391,402,290.83265,763,514.46
营业总成本157,965,262.18553,727,749.83396,611,989.68264,855,371.94
营业利润11,119,439.093,633,016.26,433,317.1210,498,051.14
利润总额11,059,785.943,535,116.376,465,187.1510,569,313.61
净利润11,973,873.8217,083,154.8315,243,605.8515,976,491.16
其他综合收益-81,158.6964,923.15-4,824.99-51,900.47
综合收益总额11,892,715.1317,148,077.9815,238,780.8615,924,590.69
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计584,490,479.58554,317,975.45620,478,092.95670,518,249.22
非流动资产合计746,779,546762,108,412.74737,683,056.6740,662,016.46
资产总计1,331,270,025.581,316,426,388.191,358,161,149.551,411,180,265.68
流动负债合计134,091,501.45125,397,520.57150,656,447.31181,679,349.69
非流动负债合计150,934,307.26158,331,409.82162,956,894.05166,544,310.07
负债合计285,025,808.71283,728,930.39313,613,341.36348,223,659.76
归属于母公司股东权益合计1,046,244,216.871,032,697,457.81,044,547,808.191,062,956,605.92
股东权益合计1,046,244,216.871,032,697,457.81,044,547,808.191,062,956,605.92
负债和股东权益合计1,331,270,025.581,316,426,388.191,358,161,149.551,411,180,265.68
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计128,078,776.98539,351,247.7387,357,197.61226,223,460.75
经营活动现金流出小计129,955,084.88458,487,717.95366,250,165.13247,815,577.95
经营活动产生的现金流量净额-1,876,307.980,863,529.7521,107,032.48-21,592,117.2
投资活动现金流入小计10,059,178.08622,973,363.97597,246,631.55468,501,638.68
投资活动现金流出小计16,339,135.58667,795,592.82590,153,655.98454,464,319.1
投资活动产生的现金流量净额-6,279,957.5-44,822,228.857,092,975.5714,037,319.58
筹资活动现金流入小计7,653,171.3419,654,670.8919,654,670.8919,654,670.89
筹资活动现金流出小计6,321,483.55157,260,798.68130,641,879.5499,443,466.45
筹资活动产生的现金流量净额1,331,687.79-137,606,127.79-110,987,208.65-79,788,795.56
汇率变动对现金及现金等价物的影响1,322,735.544,816,818.382,791,150.462,602,145.9
现金及现金等价物净增加额-5,501,842.07-96,748,008.51-79,996,050.14-84,741,447.28
期末现金及现金等价物余额33,247,105.138,748,947.1755,500,905.5450,755,508.4
最新报告期:2025-06-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通0.330.470.692025-06-06
太平洋周豫,张崴0.330.460.722025-04-28
太平洋周豫,张崴0.260.440.812025-04-23
TOP↑